Studies evaluating treatment for unresectable hepatocellular carcinoma and metastatic uveal melanoma are highlighted.
FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in the United States for the treatment of inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback